![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGAP21 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1322264 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of ARHGAP21 mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | RGD:1311028 | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | RGD:1322264 | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1322264 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ARHGAP21 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1311028 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARHGAP21 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1322264 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARHGAP21 mRNA | CTD | PMID:26290441 | 2-hydroxypropanoic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of ARHGAP21 mRNA | CTD | PMID:30851411 | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1322264 | 6480464 | 3 more ... | CTD | PMID:19467301 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1322264 | 6480464 | Fenretinide results in decreased expression of ARHGAP21 mRNA | CTD | PMID:28973697 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of ARHGAP21 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of ARHGAP21 mRNA | CTD | PMID:33212167 | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of ARHGAP21 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of ARHGAP21 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to ARHGAP21 mRNA] | CTD | PMID:32406909 | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of ARHGAP21 mRNA | CTD | PMID:20458559 | benzo[a]pyrene | increases mutagenesis | EXP | | 6480464 | Benzo(a)pyrene results in increased mutagenesis of ARHGAP21 gene | CTD | PMID:25435355 | benzo[a]pyrene | decreases methylation | ISO | RGD:1322264 | 6480464 | Benzo(a)pyrene results in decreased methylation of ARHGAP21 intron | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1322264 | 6480464 | Benzo(a)pyrene results in increased expression of ARHGAP21 mRNA | CTD | PMID:19770486 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | bis(2-chloroethyl) sulfide | increases phosphorylation | EXP | | 6480464 | Mustard Gas results in increased phosphorylation of ARHGAP21 protein | CTD | PMID:19845377 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ARHGAP21 mRNA | CTD | PMID:22574217 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of ARHGAP21 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | RGD:1311028 | 6480464 | bisphenol A results in decreased expression of ARHGAP21 mRNA | CTD | PMID:25181051, PMID:30816183 | Brodifacoum | decreases expression | ISO | RGD:1311028 | 6480464 | bromfenacoum results in decreased expression of ARHGAP21 protein | CTD | PMID:28903499 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of ARHGAP21 mRNA | CTD | PMID:26079696 | cadmium dichloride | decreases expression | ISO | RGD:1311028 | 6480464 | Cadmium Chloride results in decreased expression of ARHGAP21 mRNA | CTD | PMID:33453195 | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of ARHGAP21 protein | CTD | PMID:35688186 | carbon nanotube | decreases expression | ISO | RGD:1322264 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ARHGAP21 gene] | CTD | PMID:28238834 | chloropicrin | increases expression | EXP | | 6480464 | chloropicrin results in increased expression of ARHGAP21 mRNA | CTD | PMID:26352163 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of ARHGAP21 mRNA | CTD | PMID:19549813 | coumarin | affects phosphorylation | EXP | | 6480464 | coumarin affects the phosphorylation of ARHGAP21 protein | CTD | PMID:35688186 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ARHGAP21 mRNA | CTD | PMID:20106945, PMID:25562108 | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of ARHGAP21 mRNA | CTD | PMID:20458559 | dibutyl phthalate | increases expression | ISO | RGD:1322264 | 6480464 | Dibutyl Phthalate results in increased expression of ARHGAP21 mRNA | CTD | PMID:21266533 | dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of ARHGAP21 mRNA | CTD | PMID:17720352 | epoxiconazole | decreases expression | ISO | RGD:1322264 | 6480464 | epoxiconazole results in decreased expression of ARHGAP21 mRNA | CTD | PMID:35436446 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of ARHGAP21 mRNA | CTD | PMID:20655997 | methidathion | decreases expression | ISO | RGD:1322264 | 6480464 | methidathion results in decreased expression of ARHGAP21 mRNA | CTD | PMID:34813904 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of ARHGAP21 mRNA | CTD | PMID:28001369 | N,N-diethyl-m-toluamide | multiple interactions | ISO | RGD:1311028 | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of ARHGAP21 gene | CTD | PMID:33148267 | oxaliplatin | multiple interactions | ISO | RGD:1311028 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ARHGAP21 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | RGD:1322264 | 6480464 | Acetaminophen affects the expression of ARHGAP21 mRNA | CTD | PMID:17562736 | permethrin | multiple interactions | ISO | RGD:1311028 | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of ARHGAP21 gene | CTD | PMID:33148267 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARHGAP21 mRNA | CTD | PMID:19710929 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of ARHGAP21 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGAP21 mRNA | CTD | PMID:22079256 | quercetin | decreases phosphorylation | EXP | | 6480464 | Quercetin results in decreased phosphorylation of ARHGAP21 protein | CTD | PMID:35688186 | rac-lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of ARHGAP21 mRNA | CTD | PMID:30851411 | serpentine asbestos | increases methylation | EXP | | 6480464 | Asbestos, Serpentine results in increased methylation of ARHGAP21 5' UTR | CTD | PMID:29523930 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of ARHGAP21 mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of ARHGAP21 mRNA | CTD | PMID:31758290 | topotecan | multiple interactions | ISO | RGD:1311028 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ARHGAP21 mRNA | CTD | PMID:25729387 | topotecan | decreases expression | ISO | RGD:1311028 | 6480464 | Topotecan results in decreased expression of ARHGAP21 mRNA | CTD | PMID:25729387 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of ARHGAP21 mRNA | CTD | PMID:28818685 | valproic acid | affects splicing | ISO | RGD:1311028 | 6480464 | Valproic Acid affects the splicing of ARHGAP21 mRNA | CTD | PMID:29427782 | vinclozolin | increases methylation | ISO | RGD:1311028 | 6480464 | vinclozolin results in increased methylation of ARHGAP21 gene | CTD | PMID:31079544 | |